Catalent Inc (CTLT)
59.66
+0.66
(+1.12%)
USD |
NYSE |
Nov 21, 16:00
59.66
0.00 (0.00%)
After-Hours: 19:47
Catalent Price to Book Value: 3.057 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 3.024 |
November 19, 2024 | 3.017 |
November 18, 2024 | 3.012 |
November 15, 2024 | 3.029 |
November 14, 2024 | 3.019 |
November 13, 2024 | 3.031 |
November 12, 2024 | 3.036 |
November 11, 2024 | 3.047 |
November 08, 2024 | 3.044 |
November 07, 2024 | 3.071 |
November 06, 2024 | 3.072 |
November 05, 2024 | 2.997 |
November 04, 2024 | 3.008 |
November 01, 2024 | 3.010 |
October 31, 2024 | 3.003 |
October 30, 2024 | 3.022 |
October 29, 2024 | 3.006 |
October 28, 2024 | 3.014 |
October 25, 2024 | 3.028 |
October 24, 2024 | 3.049 |
October 23, 2024 | 3.044 |
October 22, 2024 | 3.071 |
October 21, 2024 | 3.084 |
October 18, 2024 | 3.089 |
October 17, 2024 | 3.079 |
Date | Value |
---|---|
October 16, 2024 | 3.089 |
October 15, 2024 | 3.108 |
October 14, 2024 | 3.108 |
October 11, 2024 | 3.097 |
October 10, 2024 | 3.111 |
October 09, 2024 | 3.124 |
October 08, 2024 | 3.113 |
October 07, 2024 | 3.106 |
October 04, 2024 | 3.105 |
October 03, 2024 | 3.111 |
October 02, 2024 | 3.097 |
October 01, 2024 | 3.086 |
September 30, 2024 | 3.104 |
September 27, 2024 | 3.038 |
September 26, 2024 | 3.036 |
September 25, 2024 | 3.014 |
September 24, 2024 | 3.028 |
September 23, 2024 | 3.008 |
September 20, 2024 | 3.021 |
September 19, 2024 | 3.027 |
September 18, 2024 | 3.037 |
September 17, 2024 | 3.039 |
September 16, 2024 | 3.029 |
September 13, 2024 | 3.002 |
September 12, 2024 | 3.005 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.219
Minimum
May 16 2023
6.212
Maximum
Sep 08 2021
3.738
Average
3.922
Median
Price to Book Value Benchmarks
Eli Lilly and Co | 49.99 |
Boston Scientific Corp | 6.512 |
Pfizer Inc | 1.543 |
Merck & Co Inc | 5.676 |
BioCardia Inc | 3.580 |
Price to Book Value Related Metrics
PS Ratio | 2.452 |
Price to Free Cash Flow | 109.53 |
Price | 59.66 |
Earnings Yield | -3.80% |
Market Cap | 10.83B |